President Sharon Lewin On Full Results From PURPOSE 1 Trial Of Twice-yearly Injectable Lenacapavir For HIV Prevention

“Much of this work is underway this week at AIDS 2024, and will continue at HIVR4P 2024, the 5th HIV Research for Prevention Conference, which will take place in Lima, Peru, and virtually from 6 to 10 October 2024.”